Management of children with febrile seizures: a Greek nationwide survey

Ioannis Kopsidas1,2, Foteini Eleni Dasoula3, Eleni Kourkouni4

  • 1Second Department of Pediatrics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece. j.kopsidas@outlook.com.

Insights

Pediatricians in Greece often use outdated practices for managing childhood febrile seizures, despite knowing they are ineffective. Further training is crucial to align practices with current evidence-based guidelines.

Area of Science:

  • Pediatrics
  • Neurology

Background:

  • Current guidelines for childhood febrile seizures do not support aggressive fever management, specialist referral, or hospitalization.
  • Parents may seek aggressive treatments due to distress from uninformed views on febrile seizures.

Purpose of the Study:

  • To investigate pediatrician knowledge, principles, and practices in managing febrile seizures in Greece.
  • To identify gaps between current guidelines and actual clinical practices.

Main Methods:

  • A cross-sectional study involving 457 pediatricians across Greece.
  • Anonymous questionnaires (paper and online) assessed knowledge, attitudes, and practices regarding febrile seizure management.
  • Descriptive statistics and group comparisons were performed.

Main Results:

  • 63% of pediatricians suggested aggressive fever management or systematic specialist referral, and 67% recommended hospitalization for subsequent episodes, despite 72% acknowledging inefficacy.
  • 28% believed aggressive fever management could delay febrile seizures, associated with increasing age.
  • Older pediatricians were more likely to use non-evidence-based practices but also more likely to inform parents proactively.

Conclusions:

  • Many Greek pediatricians employ outdated and ineffective febrile seizure management strategies.
  • A significant gap exists between evidence-based guidelines and clinical practice, necessitating further practitioner training.

Related Concept Videos

Methods of reducing fever01:22

Methods of reducing fever

The signs and symptoms of fever include hot and dry skin, flushed face, thirst, muscle aches, anorexia, headache, tachycardia, tachypnea, and fatigue. Elevated body temperature is reduced using two methods: pharmacological and nonpharmacological. Proper identification and treatment of the root cause of a fever is of utmost importance.
Pharmacological Methods of Reducing Fever:
712
Increased Body Temperature01:25

Increased Body Temperature

A body temperature above  38°C  (100.4 °F) is known as fever or pyrexia, and a person with fever is termed 'febrile.' Typically, the hypothalamus, a part of the brain that acts as the body's thermostat, regulates body temperature through a thermoregulatory setpoint. It receives signals from cold and warm thermal receptors throughout the body and adjusts the body's temperature accordingly. Fever occurs when this hypothalamic setpoint is altered, usually in...
729
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
232
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
460
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
475
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
357